Planet 13 Holdings (PLNH) Change in Account Payables (2022 - 2026)
Planet 13 Holdings' (PLNH) quarterly Change in Account Payables came in at -$483957.0 in Q1 2026, up 69.44% year-on-year from -$285627.8 in Q1 2025, and up 7.43% on a QoQ basis from -$522790.0 in Q3 2025.
Planet 13 Holdings (PLNH) Change in Account Payables (2022 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 5 years of Change in Account Payables data on file, last reported at -$483957.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables rose 69.44% year-over-year to -$483957.0 in Q1 2026; TTM through Mar 2026 was -$1.4 million, a 138.33% decrease from a year earlier, with the FY2024 full-year figure at $4.3 million, up 1353.09% from the prior year.
- Change in Account Payables for Q1 2026 stood at -$483957.0, up from -$522790.0 in the prior quarter.
- Over the last five years, Change in Account Payables for PLNH reached as high as $2.8 million in Q4 2024 and fell as low as -$1.6 million in Q1 2025.
- Historically, Change in Account Payables has averaged $264201.1 across 5 years, with a median of -$13497.5 in 2023.
- On a YoY basis, Change in Account Payables climbed as much as 4743.38% in 2024 and fell as far as 133.51% in 2024.
- Year by year, Change in Account Payables stood at $387084.0 in 2022, then plunged by 85.05% to $57858.0 in 2023, then soared by 4743.38% to $2.8 million in 2024, then tumbled by 118.66% to -$522790.0 in 2025, then grew by 7.43% to -$483957.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were -$483957.0 in Q1 2026, -$522790.0 in Q3 2025, and $1.2 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 30.60 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.70 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -483,957.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -483,957.00 |
| Mar 31, 2026 | -483,957.00 |
| Sep 30, 2025 | -522,790.00 |
| Sep 30, 2025 | -522,790.00 |
| Jun 30, 2025 | 1.22 Mn |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Dec 31, 2024 | 2.80 Mn |
| Sep 30, 2024 | 2.45 Mn |
| Sep 30, 2024 | 2.45 Mn |
| Jun 30, 2024 | -84,853.00 |
| Jun 30, 2024 | -84,853.00 |
| Mar 31, 2024 | -829,695.00 |
| Mar 31, 2024 | -829,695.00 |
| Dec 31, 2023 | 57,858.00 |
| Dec 31, 2023 | 57,858.00 |
| Sep 30, 2023 | -137,318.00 |
| Sep 30, 2023 | -137,318.00 |